End-of-day quote
Shanghai S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
16.75
CNY
|
+3.97%
|
|
+6.62%
|
+14.18%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
22,824
|
49,180
|
32,246
|
32,429
|
21,592
|
24,653
|
-
|
-
|
Enterprise Value (EV)
1 |
24,627
|
51,018
|
32,246
|
37,867
|
27,214
|
27,189
|
26,966
|
24,653
|
P/E ratio
|
38.4
x
|
52.8
x
|
63.7
x
|
27.3
x
|
25.7
x
|
22
x
|
17.2
x
|
-
|
Yield
|
1.16%
|
0.59%
|
0.46%
|
1.1%
|
1.36%
|
1.28%
|
1.73%
|
1.31%
|
Capitalization / Revenue
|
4.24
x
|
7.58
x
|
4.85
x
|
3.92
x
|
2.6
x
|
2.44
x
|
2.16
x
|
-
|
EV / Revenue
|
4.57
x
|
7.87
x
|
4.85
x
|
4.58
x
|
3.28
x
|
2.69
x
|
2.36
x
|
-
|
EV / EBITDA
|
19.9
x
|
29
x
|
-
|
17.2
x
|
14.4
x
|
11.4
x
|
9.44
x
|
-
|
EV / FCF
|
-
|
16,39,61,201
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.07
x
|
7.84
x
|
5.11
x
|
4.44
x
|
2.78
x
|
2.79
x
|
2.45
x
|
-
|
Nbr of stocks (in thousands)
|
14,54,610
|
14,54,608
|
14,88,714
|
14,83,475
|
14,71,850
|
14,71,850
|
-
|
-
|
Reference price
2 |
15.69
|
33.81
|
21.66
|
21.86
|
14.67
|
16.75
|
16.75
|
16.75
|
Announcement Date
|
30/04/20
|
08/04/21
|
18/04/22
|
17/04/23
|
16/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,388
|
6,485
|
6,644
|
8,266
|
8,309
|
10,102
|
11,406
|
-
|
EBITDA
1 |
1,237
|
1,760
|
-
|
2,207
|
1,896
|
2,389
|
2,858
|
-
|
EBIT
1 |
824.4
|
1,287
|
868.4
|
1,547
|
1,125
|
1,493
|
1,975
|
-
|
Operating Margin
|
15.3%
|
19.84%
|
13.07%
|
18.72%
|
13.53%
|
14.78%
|
17.32%
|
-
|
Earnings before Tax (EBT)
1 |
760.9
|
1,215
|
786.9
|
1,509
|
1,100
|
1,493
|
1,838
|
-
|
Net income
1 |
569.6
|
929.8
|
487.5
|
1,168
|
830.5
|
1,121
|
1,417
|
-
|
Net margin
|
10.57%
|
14.34%
|
7.34%
|
14.13%
|
10%
|
11.1%
|
12.42%
|
-
|
EPS
2 |
0.4091
|
0.6400
|
0.3400
|
0.8000
|
0.5700
|
0.7600
|
0.9750
|
-
|
Free Cash Flow
|
-
|
311.2
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
4.8%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
17.68%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
33.46%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1818
|
0.2000
|
0.1000
|
0.2400
|
0.2000
|
0.2150
|
0.2900
|
0.2200
|
Announcement Date
|
30/04/20
|
08/04/21
|
18/04/22
|
17/04/23
|
16/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
1,773
|
2,051
|
2,014
|
2,428
|
2,059
|
2,235
|
1,913
|
-
|
2,499
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
200.8
|
499.9
|
329.7
|
516.8
|
243.6
|
450.5
|
230.3
|
-
|
374.6
|
-
|
-
|
-
|
Operating Margin
|
11.33%
|
24.38%
|
16.36%
|
21.29%
|
11.83%
|
20.15%
|
12.04%
|
-
|
14.99%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
1 |
0.1000
|
0.2900
|
0.1600
|
0.2500
|
0.1200
|
0.2700
|
0.1100
|
0.0700
|
0.1900
|
0.2500
|
0.2200
|
0.1800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/04/22
|
30/08/22
|
29/10/22
|
17/04/23
|
28/04/23
|
30/08/23
|
31/10/23
|
16/04/24
|
29/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
1,803
|
1,838
|
-
|
5,439
|
5,622
|
2,535
|
2,312
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.458
x
|
1.044
x
|
-
|
2.465
x
|
2.966
x
|
1.061
x
|
0.809
x
|
Free Cash Flow
|
-
|
311
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.2%
|
15.6%
|
7.43%
|
16.6%
|
10.6%
|
13.2%
|
15.1%
|
ROA (Net income/ Total Assets)
|
-
|
7.84%
|
-
|
6.95%
|
-
|
5.9%
|
7.3%
|
Assets
1 |
-
|
11,860
|
-
|
16,810
|
-
|
19,000
|
19,405
|
Book Value Per Share
2 |
3.860
|
4.310
|
4.240
|
4.930
|
5.290
|
6.010
|
6.840
|
Cash Flow per Share
2 |
1.210
|
1.070
|
0.6300
|
0.8400
|
1.500
|
1.070
|
1.090
|
Capex
1 |
790
|
1,244
|
-
|
2,306
|
1,588
|
429
|
570
|
Capex / Sales
|
14.66%
|
19.19%
|
-
|
27.89%
|
19.11%
|
4.25%
|
5%
|
Announcement Date
|
30/04/20
|
08/04/21
|
18/04/22
|
17/04/23
|
16/04/24
|
-
|
-
|
Last Close Price
16.75
CNY Average target price
18.17
CNY Spread / Average Target +8.46% Consensus |
1st Jan change
|
Capi.
|
---|
| +14.18% | 3.41B | | +33.25% | 704B | | +28.59% | 577B | | -3.55% | 348B | | +18.16% | 327B | | +4.36% | 288B | | +14.81% | 234B | | +4.93% | 198B | | -9.78% | 194B | | -3.69% | 147B |
Other Pharmaceuticals
|